Kolexia
Burgy Mickaël Oncologie médicale
Burgy Mickaël
Oncologie médicale
Centre Paul Strauss
Strasbourg, France
54 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinome épidermoïde de la tête et du cou Carcinomes Carcinome épidermoïde Tumeurs de la tête et du cou Récidive tumorale locale Métastase tumorale Néphrocarcinome Tumeurs du rein Tumeurs osseuses

Collaborateurs

Voir plus
Borel Christian
Borel Christian
Centre Paul Strauss, Strasbourg, France
Barthelemy Philippe
Barthelemy Philippe
Hôpital Civil, Strasbourg, France
Schultz Philippe-Emmanuel
Schultz Philippe-Emmanuel
Hôpital Hautepierre, Strasbourg, France
Pierard Laure
Pierard Laure
Hôpital Hautepierre, Strasbourg, France

Industries

Voir plus
Ipsen
7 collaboration(s)
Dernière en 2022
Pfizer
5 collaboration(s)
Dernière en 2023
MSD
4 collaboration(s)
Dernière en 2023
Janssen
4 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
IMMUNONET: A Multicenter, Open-label, Proof of Concept Phase II Aiming to Assess the Clinical and Biological Activity of Anti-netrin-1 (NP137) as Add on Therapy in Patients With Advanced/Metastatic Solid Tumors Treated by Standard Immunotherapies
Essai Clinique (NETRIS Pharma)   06 mars 2024
MOST plus: A Two-period, Multicenter, Randomized, Open-label, Phase II Study Evaluating the Clinical Benefit of a Maintenance Treatment Targeting Tumor Molecular Alterations in Patients With Progressive Locally-advanced or Metastatic Solid Tumors
Essai Clinique (Centre Léon-Bérard)   09 février 2024
Dynamic profiling of immune microenvironment during anti-PD-1 immunotherapy for head and neck squamous cell carcinoma: the IPRICE study.
BMC cancer   08 décembre 2023
MegaMOST - A Multicenter, Open-label, Biology Driven, Phase II Study Evaluating the Activity of Anti-cancer Treatments Targeting Tumor Molecular Alterations /Characteristics in Advanced / Metastatic Tumors.
Essai Clinique (Centre Léon-Bérard)   16 novembre 2023
A novel ΔNp63-dependent immune mechanism improves prognosis of HPV-related head and neck cancer.
Frontiers in immunology   25 octobre 2023
PembroMetaRT: Randomized Trial of Loco-regional Radiotherapy Added to Pembrolizumab Alone or With Chemotherapy Versus Systemic Treatment Alone for Patients With Newly Diagnosed Head and Neck Squamous Cell Carcinoma With Synchronous Metastases
Essai Clinique (Unicancer)   12 octobre 2023
IPRICE: Identification of Predictive Factors for the Response to Anti-Programmed Cell Death Protein 1 (PD1) Immunotherapy in Head and Neck Squamous Cell Carcinoma
Essai Clinique (Institut de cancérologie Strasbourg Europe)   21 septembre 2023
Molecular imaging and related therapeutic options for medullary thyroid carcinoma: state of the art and future opportunities.
Reviews in endocrine & metabolic disorders   16 septembre 2023
Tumor-Suppressive and Immunomodulating Activity of miR-30a-3p and miR-30e-3p in HNSCC Cells and Tumoroids.
International journal of molecular sciences   06 juillet 2023
Liens entre vaccins anti-Covid et cancer : "Nous, cancérologues ...
L'Express   18 mars 2023